http://www.ncbi.nlm.nih.gov/pubmed/21178719
J Thorac Oncol. 2011 Jan;6(1):220-222.
KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma.
Ortiz TM, Cohen DW, Kent MS, Jänne PA, Costa DB.
*Division of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School; and †Departments of Surgery, Pathology, and Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
No comments:
Post a Comment